Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 198-209 , September 2008

Photodynamic therapy of C6-implanted glioma cells in the rat brain employing second-generation photosensitizer talaporfin sodium

  • Hiroaki Namatame, MD

      Affiliations

    • Department of Neurosurgery, Tokyo Medical University, Japan
    • ,
  • Jiro Akimoto, MD

      Affiliations

    • Department of Neurosurgery, Tokyo Medical University, Japan
    • Corresponding Author InformationCorresponding author at: Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, 160-0023 Tokyo, Japan. Tel.: +81 3 3342 6111x5773; fax: +81 3 3340 4285.
    • ,
  • Hiroyuki Matsumura, MD

      Affiliations

    • Department of Neurosurgery, Tokyo Medical University, Japan
    • ,
  • Jo Haraoka, MD

      Affiliations

    • Department of Neurosurgery, Tokyo Medical University, Japan
    • ,
  • Katsuo Aizawa, PhD

      Affiliations

    • Department of Physiology, Tokyo Medical University, Japan

References 

  1. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190–198
  2. Sawaya R, Hammound M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42:1044–1056
  3. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 2006;7:392–401
  4. Wilson CB. Glioblastoma: the past, the present, and the future. Clin Neurosurg. 1992;38:32–48
  5. Stummer W, Novotny A, Stepp H, Goets C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003–1013
  6. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B. 1996;36(2):157–168
  7. Perria C, Capuzzo T, Cavagnaro C, Datti R, Francaviglia N, Rivano C, et al. Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci. 1980;24:119–129
  8. Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massareli G, et al. Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery. 1988;23:557–563
  9. Nelson JS, Roberts WG, Berns MW. In vivo studies on the utilization of mono-l-aspartyl chlorine (NPe6) for photodynamic therapy. Cancer Res. 1987;47:4681–4685
  10. Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst. 1988;80:1599–1605
  11. Bogaards A, Varma A, Zhang K, Zach D, Bisland SK, Moriyama EH, et al. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochem Photobiol Sci. 2005;4:438–442
  12. Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. Proc Natl Acad Sci. 1995;92:12126–12130
  13. Bisland SK, Ligle A, Lin A, Runsnov R, Wilson BC. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol. 2004;80:22–30
  14. Ligle L, Wilson BC. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg. 1998;16(2):81–91
  15. Ligle L, Portnoy M, Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumor tissue. Br J Cancer. 2000;83(3):1110–1117
  16. Muller PJ, Wilson BC. Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg. 1996;4:263–270
  17. Muller PJ, Wilson BC. Photodynamic therapy of brain tumors—a work in progress. Lasers Surg Med. 2006;38:384–389
  18. Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, et al. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol. 2001;19(2):519–524
  19. Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma-long term survival. J Clin Neurosci. 2005;12(4):389–398
  20. Angell-Petersen E, Spetalen S, Madsen SJ, Sun C-H, Peng Q, Carper SW, et al. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg. 2006;104:109–117
  21. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neuro-Oncol. 2003;62:243–250
  22. Madsen SJ, Angell-Petersen E, Spetalen S, Carper SW, Ziegler SA, Hirschberg H. Photodynamic therapy of newly implanted glioma cells in the rat brain. Lasers Surg Med. 2006;38:540–548
  23. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg. 2002;97:970–976
  24. Eljamel M, Goodman C, Moseley H. ALA and Photofrin fluorescence guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomized controlled trial. Lasers Med Sci. 2008;23(4):361–367
  25. Eljamel S. Photodynamic assisted surgical resection and treatment of malignant brain tumours; technique, technology and clinical application. Photodiag Photudyn Ther. 2004;1:93–98
  26. Kaye AH, Morstyn G, Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma, a phase I/II study. J Neurosurg. 1987;67:500–505
  27. Kostron H, Fritsch E, Grunert V . Photodynamic therapy of malignant brain tumors; a phase I/II trial. Br J Neurosurg. 1988;2:241–248
  28. Aizawa K, Okunaka T, Ohtani T, Kawabe H, Yasunaka Y, O’Hata S, et al. Localization of mono-l-aspartyl chlorine e6 (Npe6) in mouse tissue. Photochem Photobiol. 1987;46(5):789–793
  29. Matsumura H, Akimoto J, Haraoka J, Aizawa K. Uptake and retention of novel photosensitizer mono-l-aspartyl chlorine e6 in experimental malignant glioma. Laser Med Sci. 2008;23(3):237–245
  30. Tsuchida T, Aizawa K, Konaka C, Kato H. Interaction of bovine serum albumin with mono-l-asparthyl chlorine e6 by spectrophotometry. Lasers Life Sci. 1993;5(3):155–164
  31. Ferrario A, Kessel D, Gomer CJ. Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res. 1992;52:2890–2893
  32. Gomer CJ, Ferrario A. Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res. 1990;50:3985–3990
  33. Katsumi T, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Yl, et al. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorine e6. Photochem Photobiol. 1996;64:671–675
  34. Kaneko T, Chiba H, Yasuda T, Kusama K. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. Oral Oncol. 2004;40:787–792
  35. Louis-Michel WKS, Wang KK, Zinsmeister AR. Mono-l-aspartyl chlorine e6 (Npe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer. 1998;82:421–427
  36. Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-l-aspartyl chlorine e6 (NPe6) against uterine cervical carcinoma cell lines. Int J Gynecol Cancer. 2002;12:177–186
  37. Habeda KM, Kamphorst W, Sterenborg HJ, Wolbers JG. Damage to tumor and brain by interstitial photodynamic therapy in the 9L rat tumor model comparing intravenous and intratumoral administration of the photosensitizer. Acta Neurochir (Wien). 1998;140:495–501
  38. Roberts WG, Berns MW. In vitro photosensitization. I. Cellular uptake and subcellular localization of mono-l-aspartyl chlorine e6, chloro-aluminium sulfonated phthalocyanine, and photofrin II. Lasers Surg Med. 1989;9(2):90–101
  39. Chen Q, Chopp M, Madigan L, Dreski MO, Hetzel FW. Damage threshold of normal brain in photodynamic therapy. Photochem Photobiol. 1996;64:163–167
  40. Dereski MO, Chopp M, Gracia JH, Hetzel FW. Depth measurements and histopathological characterization of photodynamic therapy generated normal brain necrosis as a function of incident optical energy dose. Photochem Photobiol. 1991;54:109–112
  41. Yoshida Y, Dereski MO, Garcia JH, Hetzel FW, Chopp M. Neuronal injury after photoactivation of photofrin II. Am J Pathol. 1992;141:989–997
  42. Yoshida Y, Dereski MO, Garcia JH, Hetzel FW, Chopp M. Photoactivated photofrin II: astrocytic swelling precedes endothelial injury in rat brain. J Neuropath Exp Neurol. 1992;51:91–100
  43. Kessel D, Luo Y, Mathieu P, Reiners JJ. Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol. 2000;65:410–415
  44. Kessel D, Graca M, Vicente H, Reiners JJ. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med. 2006;38:482–488
  45. Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW. In vitro characterization of monoaspartyl chlorine e6 and diaspartyl chlorine e6 for photodynamic therapy. J Natl Cancer Inst. 1988;80(5):330–336
  46. Reiners JJ, Carso JA, Matieu P, Chelladurai B, Yin XM, Kessel D. Release of cytochrome c and activation of procaspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 2002;9:934–944
  47. Stolka V, Turk B, Schendel SL, Kim T-H, Cirman T, Snipes SJ, et al. Lysosomal protease pathways to apoptosis: cleavage Bid, not pro-caspases, is the most likely route. J Chem. 2001;276:3149–3157
  48. Yamamoto Y, Shibuya H, Okunaka T, Aizawa K, Kato H. Fibrin plugging as a cause of microcirculatory occlusion during photodynamic therapy. Lasers Med Sci. 1999;14:129–135
  49. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 1994;54:4564–4568

PII: S1572-1000(08)00075-6

doi: 10.1016/j.pdpdt.2008.08.001

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 198-209 , September 2008

Article Tools

* Image Usage & Resolution